AstraZeneca strikes $40 million AI drug discovery deal with insitro
AstraZeneca has entered into a partnership with insitro to identify treatments for challenging liver and heart diseases. This collaboration, which involves a $40 million upfront payment, could reach $1.46 billion in total milestones. The companies aim to tackle metabolic dysfunction-associated steatohepatitis and cardiomyopathies through insitro's AI platform.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)